FOLH1 and posterior cortical atrophy: The continued evaluation of patient selection criteria, long-term oncologic outcomes, and comparative studies against standard-of-care surgical techniques will be crucial in defining the precise role of PSMA-RGS in the management of recurrent and metastatic PCa.